SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Charles River Laboratories International, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 18, 2023 - (NYSE: CRL)
Werte in diesem Artikel
NEW YORK, July 12, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Charles River Laboratories International, Inc..
Shareholders who purchased shares of CRL during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.
CONTACT US HERE:
https://securitiesclasslaw.com/securities/charles-river-loss-submission-form/?id=41965&from=4
CLASS PERIOD: May 5, 2020 to February 21, 2023
ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) Charles River had engaged in illegal activity with respect to its importation of non-human primates for research; (2) as a result, Charles River was at a heightened risk of criminal and regulatory investigation by, inter alia, the U.S. Department of Justice; (3) as a result, Charles River would be forced to suspend shipments of primates from Cambodia; and (4) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
DEADLINE: July 18, 2023 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/charles-river-loss-submission-form/?id=41965&from=4
NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of CRL during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is July 18, 2023. There is no cost or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
SOURCE The Gross Law Firm
Ausgewählte Hebelprodukte auf Charles River Laboratories International
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Charles River Laboratories International
Der Hebel muss zwischen 2 und 20 liegen
Aktuelle Charles River Laboratories International Aktie News
Charles River Laboratories International Analysen
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Charles River Laboratories International nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen
| Datum | Rating | Analyst | |
|---|---|---|---|
| 14.12.18 | Charles River Laboratories International Buy | Deutsche Bank AG | |
| 19.09.17 | Charles River Laboratories International Sector Perform | RBC Capital Markets | |
| 30.11.16 | Charles River Laboratories International Equal Weight | Barclays Capital | |
| 06.09.16 | Charles River Laboratories International Sell | UBS AG | |
| 20.05.16 | Charles River Laboratories International Underweight | Barclays Capital |